PRIME exits and American HealthCare Capital are pleased to exclusively present a company with highly profitable, rapidly growing, multi-location ABA, Speech, and Occupational Therapy Centers for sale near a major metropolitan city in the Midwest. The vast majority of the revenue is generated through center-based ABA treatment of children 18 months to 12 years of age. The company has an outstanding reputation for excellence in the highly populated communities it serves, as evidenced by its robust waitlist. In 2023, the company’s revenue was $3.06 million with an adjusted EBITDA of $831,539, up from 2022 revenue of $2.0 million and adjusted EBITDA of $556,000. 2024 is expected to be another year of 50% top-line growth for the company. Current projections are pointing to $4.5 million in revenues and $1.2 million in adjusted EBITDA by year end 2024 given, among other factors, the opening of a new center which already has a committed list of clients. The owners are incredibly proud of the company and reputation they have built but have arrived at a stage in their lives where they’re ready to move on to their next adventure. They are willing to stay on for a period of time to assist with a smooth transition if desired, but the current leadership team, which has been in place for years, is exceptionally well positioned to take the reins. Given the significant revenue and EBITDA growth expected in 2024, and based on forecasted TTM adjusted EBITDA from July 1, 2023 through June 30, 2024, the asking price for this opportunity is currently targeted at $6.65 million with the owners open to a deal structure that includes an earnout.